Background and objective: During recent years, some persistent organic pollutants (POPs) have been linked to atherosclerosis. One group of POPs, the poly-and perfluoroalkyl substances (PFASs) have not been investigated with regard to atherosclerotic plaques. Methods: Carotid artery atherosclerosis was assessed by ultrasound in 1016 subjects aged 70 years in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Eight PFASs were detected in > 75% of participants' plasma by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS). Results: No significant linear associations were observed between the PFASs and intima-media thickness (IMT), or the echogenicity in the intima-media complex (IM-GSM, a marker of lipid infiltration in the artery) when men and women were analyzed together. Neither was occurrence of carotid plaques related to PFASs levels. However, highly significant interactions were observed between some PFASs and sex regarding both IM-GSM and plaque prevalence. Perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnDA), were all related to IM-GSM in a positive fashion in women (p=0.002-0.003), while these relationships were negative in men. The levels of PFUnDA were significantly related to carotid plaque in women (OR 1.59, 95%CI 1.03-2.43, p=0.03), but not in men (OR 0.93, p=0.75). Conclusions: In this cross-sectional study, a pronounced gender difference was observed regarding associations between some PFASs, especially the long-chain PFUnDA, and markers of atherosclerosis, with more pronounced relationships found in women. These findings suggest a sex-specific role for PFASs in atherosclerosis.
Introduction
Per-and polyfluoroalkyl substances (PFASs) are a huge class of compounds used to manufacture a wide variety of industrial and household applications due to their unique properties of being both water and oil repellent. The production of PFASs was initiated in the late 1940s and ubiquitous amounts of PFASs have since then been released to the environment (Lindstrom et al., 2011) . The most widely used among the large group of PFASs are the perfluoroalkyl sulfonic acids (PFSAs) and perfluoroalkyl carboxylic acids (PFCAs), including perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). PFOS and PFOA share the feature of being fully fluorinated, eight-carbon chain organic acids (C 8 ). However, numerous perfluoroalkyls with varying carbon chain length, from four carbons to fourteen carbons (C 4 -C 14 ), can be detected in various compartments in the environment (Lau et al., 2007) .
Global regulatory actions to control the emissions and production of PFASs have only recently been implemented for perfluorooctane sulfonate (PFOS) and its precursors which were included in the Annex B of the 2009 Stockholm Convention (UNEP, 2015) . Furthermore, voluntary discontinuation agreements from major manufacturers of PFOS and PFOA have been implemented in the United States and Western Europe (US EPA, 2006 . Although recent temporal studies suggest that these phase-out policies have resulted in reduced emissions and decreasing concentrations of PFOS and PFOA in humans and wildlife (Bjerregaard-Olesen et al., 2016; Johansson et al., 2014; Nost et al., 2014; Okada et al., 2013; Rigét et al., 2013; Wang et al., 2011; Yeung et al., 2013) , it is yet unclear whether the effect is due to a change in the global production as there is a dynamic shift in the industrial production of PFASs.
The presence of PFASs in men, women, and children has been extensively reported (Bjerregaard-Olesen et al., 2016; Frisbee et al., 2009; Wang et al., 2011) and an integral part of the exposure in the general population arises through the dietary exposure including drinking water (Fromme et al., 2009) . The bioaccumulation and toxic potential of perfluoroalkyls has been suggested to increase with increased carbon-chain lengths (Liao et al., 2009; Martin et al., 2003) and the most frequently detected compounds in the general population are PFOS and PFOA followed by perfluorononanoic acid (PFNA), and perfluorohexane sulfonic acid (PFHxS) (Glynn et al., 2012; Karrman et al., 2010; Kato et al., 2011; Sundström et al., 2011; Wang et al., 2011) .
A number of adverse health effects have been linked to elevated levels of PFASs (Steenland et al., 2010a) . However, there is no uniform picture on the cardiovascular effects in response to PFASs exposure, and most studies up to date have been based on occupational or accidental settings (Borg et al., 2013; Sakr et al., 2007; Simpson et al., 2013; Steenland et al., 2010b; Winquist and Steenland, 2014 ) with a gender bias in favor of men. However, many studies show uniformly that certain PFASs are related to high serum cholesterol levels (Nelson et al., 2010; Skuladottir et al., 2015; Winquist and Steenland, 2014) . Since high serum cholesterol levels are linked to atherosclerosis, it is of importance to evaluate if cholesterol mediates possible relationships between PFASs and cardiovascular diseases.
At present, there is limited information on the relationship between PFASs exposure and atherosclerosis in a gender-balanced sample of the general population. One study found a relationship between PFOS levels and the carotid artery intima-media thickness (IMT), especially in women (Lin et al., 2013) . We have recently shown that polychlorinated biphenyls (PCBs) are related to atherosclerosis in humans (Lind et al., 2012b) . Animal experiments support that this finding is causal (Dalton et al., 2001; Wu et al., 2011) . Correspondingly, we hypothesized that also PFASs might have cardiovascular effects in the general population. We measured several PFASs in plasma from a populationbased sample of almost 1000 elderly men and women (50% women) in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS-study) (Lind et al., 2005) , with the hypothesis that elevated levels of PFASs are related to atherosclerosis measured by ultrasound in the carotid arteries in this cross-sectional study. Since previous studies have pointed towards a gender difference in the elimination of PFASs (Kudo et al., 2002) , and that PFASs might effect sex hormones (Joensen et al., 2013) , we paid special attention to the possibility that effects of PFASs on atherosclerosis are sex-specific.
We used three different indices of atherosclerosis in the present study. First, a local thickening of the intima-media complex, which is considered an established atherosclerotic plaque. Second, the intimamedia thickness (IMT) in the common carotid artery, which is a common measure of early atherosclerosis, but that could also be increased by media hypertrophy. Third, the echogenicity of the intima-media complex (denoted the intima-media grey scale median, IM-GSM), a measure of the structural composition of the arterial wall. The latter two indices are used as indicators of early changes in the carotid artery.
Material and methods

Subjects
Eligible were all subjects aged 70 living in the community of Uppsala, Sweden. The subjects were chosen from the register of community living and were invited in a randomized order. The subjects received an invitation by letter within 2 months of their 70th birthday. Of the 2025 subjects invited, 1016 subjects participated giving a participation rate of 50.1%. The investigation was conducted between 2001 and 2004.
The study was approved by the Ethics Committee of the University of Uppsala and the participants gave informed consent prior to the study.
Basic characteristics of the sample is given in Table 1 .
Basic characteristics and cardiovascular risk factors
The participants were asked to answer a questionnaire about their medical history, smoking habits and regular medication. Regarding medical history, the participants were asked if they have been given a diagnosis by a physician regarding a list of diagnoses. The smoking question was coded as current or no current smoking. All subjects were investigated in the morning after an over-night fast. No medication or smoking was allowed after midnight. After recordings of height, weight, abdominal and hip circumference, an arterial cannula was inserted in the brachial artery for blood sampling and later regional infusions of vasodilators (not dealt with in the present study). Blood pressure was measured by a calibrated mercury sphygmomanometer in the noncannulated arm to nearest mmHg after at least 30 min of rest and the average of three recordings was used. Lipid variables and fasting blood glucose were measured by standard laboratory techniques.
As the participation rate in baseline investigation of this cohort was only 50%, we carried out an evaluation of cardiovascular disorders and medications in 100 consecutive non-participants. The prevalence of cardiovascular drug intake, history of myocardial infarction, coronary revascularization, antihypertensive medication, statin use and insulin treatment were similar to those in the investigated sample, while the prevalence of diabetes, congestive heart failure and stroke tended to be P.M. Lind et al. Environmental Research 152 (2017) 157-164 higher among the non-participants (see reference Lind et al., 2005 for details).
Carotid artery ultrasound evaluation
The carotid artery was assessed by external B-mode ultrasound imaging (Acuson XP128 with a 10 MHz linear transducer, Acuson Mountain View, California, USA). The common carotid artery (CCA), the bulb and the internal carotid artery (ICA) were visualized and the occurrence of plaque was recorded on both sides. A plaque was considered to be present if the intima media thickness (IMT) was locally thickened more than 50% compared to the surrounding IMT (Hulthe et al., 1997) . The numbers of carotid arteries with plaques (0, 1 or 2) were recorded.
The images were digitized and imported into the AMS (Artery Measurement Software) automated software for dedicated analysis of intima-media thickness and the grey scale median of the intima-media complex (Liang et al., 2000) . The IMT was evaluated in the far wall in the CCA 1-2 cm proximal to the bulb. A maximal 10 mm segment with good image quality was chosen for intima-media thickness -analysis from the carotid artery. The programme automatically identifies the borders of the intima-media thickness of the far wall and the inner diameter of the vessel and calculates intima-media thickness and the diameter from around 100 discrete measurements through the 10 mm long segment. This automated analysis could be manually corrected if not found appropriate at visual inspection. The given value for carotid artery intima-media thickness is the mean value from both sides. Thus, the IMT is a measure of the thickness of the artery wall, not including the adventitia, but only the intima and media layers of the wall.
A region of interest was placed manually around the intima-media segment that was evaluated for intima-media thickness and the programme calculates the echogenicity in the intima-media complex from analysis of the individual pixels within the region of interest on a scale from 0 (black) to 256 (white). The blood was used as the reference for black and the adventitia was the reference for white. The grey scale median (GSM)-value given is the mean value from both sides (intimamedia grey scale median, IM-GSM). Thus, a low value of IM-GSM is thought of as a marker of lipid infiltration in the carotid artery wall, the first step in carotid plaque formation.
The mean length of the evaluated intima-media segments was 9.0 (SD 2.1) mm when subjects with a segment recording less than 5 mm were excluded. The measurements of intima-media thickness were repeated in 30 random subjects giving a coefficient of variation of carotid artery intima-media thickness of 7.2% and 7.5% for IM-GSM.
Methods for the chemical analysis of the PFASs
The analytical method used to determine plasma concentrations of PFASs in all samples (N=1, 016) was successfully validated in terms of recovery, accuracy, and precision (Salihovic et al., 2015 (Salihovic et al., , 2013 . Briefly, 150 µL serum extracts were analyzed using an automated columnswitching ultra-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for determination of PFASs. The current study evaluated the 8 PFASs for which > 80% of the population showed measurable levels above the lower level of detection; perfluoroheptanoic acid (PFHpA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), perfluorohexane sulfonic acid (PFHxS), linear isomer of perfluorooctane sulfonic acid (L-PFOS), perfluorooctanoic acid (PFOA) and perfluorooctane sulfonamide (PFOSA). The analytical procedure involves rapid protein precipitation using 96-well plates followed by instrumental analyses on a Acquity UPLC coupled to a Quattro Premier XE HPLC-MS/MS system (Waters Corporation, Milford, USA) with an atmospheric electrospray interface operating in negative ion mode system by injecting a 250 µL aliquot of the sample onto a C18 (2.1×20 mm, 2.5 µm) trap column connected to a C18 (2.1×100 mm, 1.7 µm) analytical column by a 6-port column switch valve. Quantitative analysis of the PFASs was performed using the internal standard method; all standards (i.e., 13 C labeled internal standards, 13 C labeled recovery standards and native calibration standards) were purchased from Wellington Laboratories (Guelph, Ontario, Canada). The method detection limits ranged between 0.01 and 0.17 ng mL −1 depending on the analyte. Medians and 25th and 75th percentile of the eight different PFASs with detectable levels (ng mL −1 ) in > 75% of the subjects are given in Suppl Table 1 .
Statistical analyses
All eight PFASs were skewed towards high levels, but were normally distributed following ln-transformation. Relationships between PFASs and number of carotid arteries with plaque (0, 1 or 2) were evaluated by ordinal logistic regression models, first using the PFASs as linear variables, and thereafter using the squared form of the PFASs to search for non-linear effects. For the continuous analysis, two steps of adjustments were used. First, adjustment for gender only, and secondly multiple adjustment for gender, LDL and HDL-cholesterol and serum triglycerides, BMI, blood pressure, smoking and exercise habits, energy and alcohol intake, diabetes and educational level. Of the 12 variables included in the model in the multiple adjustment, smoking and exercise habits, energy and alcohol intake, and educational level are life-style factors with the potential to influence PFASs levels, as well as indices of atherosclerosis. LDL and HDL-cholesterol and serum triglycerides, BMI, blood pressure and diabetes are classical risk factors for atherosclerosis, but it is less obvious that those variables could affect PFASs levels. Some of those, like cholesterol, have been linked to PFASs and could eventually be a mediator in the PFASs vs. atherosclerosis relationship.
A similar approach was used when relating PFASs to either IMT or IM-GSM. In this analysis, linear regression analysis was performed.
In order to search for sex-specific relationships, interaction terms between sex and the 8 PFASs were created and included in a separate set of models. If the interaction term was significant, analyses were also performed in men and women separately.
Structural equation models (SEM) were used to disentangle the role of mediation of serum cholesterol on the relationships between PFASs and indices of atherosclerosis.
STATA14 (Stata corp, College Station, TX, USA) was used for calculations.
Results
The mean value for IMT was 0.88 mm (0.16 SD), while the corresponding mean value for IM-GSM was 79 (23 SD). In the total sample, 273 subjects showed bilateral plaque, 343 showed unilateral plaque and 327 were free of carotid plaque.
As could be seen in Table 2 , no consistent significant linear associations were seen between the PFASs and IMT or IM-GSM when men and women were analyzed together (and adjusting for sex). Neither was occurrence of plaques in the carotid arteries related to PFASs levels (Table 4) .
Introduction of a quadratic term for the PFASs in the model did not disclose any consistent significant non-linear relationships.
However, a highly significant interaction between sex and some of the PFCAs were seen regarding IM-GSM (p=0.002 for PFNA and PFDA, p=0.0004 for PFUnDA). When men and women were analyzed separately, PFNA, PFDA, and PFUnDA were all related to IM-GSM in a positive fashion in women (beta 6.023, 95%CI (2.06, 9.986), p=0.003 for PFNA, 7.546, (2.622, 12.47), p=0.003 for PFDA and 7.045, (2.602, 11.488), p=0.002 for PFUnDA), while these relationships were negative in men (although only significantly so for PFUnDA, beta −4.574, (−9.092, −0.057), p=0.047, Fig. 1 ). Following adjustment for multiple risk factors these gender differences persisted, although at this stage only the association between PFNA and IM-GSM was still significant in women (beta 5.268, (1.048, 9.489), p=0.014). For details, see Table 3 .
Unadjusted analyses of the eight PFASs vs the three markers of atherosclerosis is given in Suppl Table 2 .
Since PFASs repeatedly have been shown to be related to cholesterol metabolism, we further investigated if the above-described relationship between PFUnDA and IM-GSM in women was mediated by cholesterol in a SEM analysis. This analysis disclosed that 3.4% of the total effect of PFUnDA on IM-GSM in women was mediated by cholesterol (p=0.012). For men, the corresponding proportion of the total effect of PFUnDA on IM-GSM being mediated by serum cholesterol was 1.7% (p=0.014).
A highly significant interaction between sex and some of the PFASs were seen also regarding carotid plaques (p=0.006 for PFOSA, p=0.005 for PFUnDA). In this case, PFUnDA was significantly related to carotid plaque in women (OR 1.59, 95%CI (1.03, 2.43), p=0.034, Fig. 2 ), but not in men (0.93, (0.62, 1.42), p=0.74). A similar tendency was seen for PFOSA (OR 1.28, (0.98, 1.66), p=0.07 in women and 0.99, (0.75, 1.29), p=0.91 in men). For details, see Table 5 .
We further investigated if the above-described relationship between PFUnDA and carotid plaques in women was mediated by cholesterol in a SEM analysis. This analysis disclosed no significant mediation of serum cholesterol on the PFUnDA vs. carotid plaques relationship (p=0.18).
In order to evaluate if common cardio-metabolic medications used in the elderly influenced the above-mentioned significant relationship, we included statins, beta-blockers, calcium antagonists, ACE-inhibitors, diuretics, insulin, oral antidiabetic agents in the models, but inclusion of those medications had only marginal effects of the significant relationships described above.
The mean glomerular filtration rate (GFR), as calculated by the Cockcroft-Gault equation, was 81 (SD 20) ml/in/m 2 in the sample, with 15% showing a GFR < 60 ml/in/m 2 . Including GFR in the models for the above-mentioned significant relationships did however only have marginal effects on these significant relationships.
Discussion
The present cross-sectional study showed that the long-chain PFASs, especially PFUnDA, were related to echogenicity of the carotid artery wall and to overt atherosclerotic plaque in women. We have Table 2 Relationships between eight different PFASs (all ln-transformed) and the intima-media thickness (IMT) (at top) and the echogenicity of the intima-media complex (IM-GSM) (below). Relationships are given both for sex-adjusted and multiple adjusted analysis (gender, HDL-and LDL-cholesterol and serum triglycerides, BMI, blood pressure, smoking exercise habits, energy and alcohol intake, diabetes and educational level). The regression coefficients (Beta), 95%CI and p-values are given for the linear models. PFASs; perfluoroheptanoic acid (PFHpA), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUn-DA), perfluorohexane sulfonic acid (PFHxS), linear isomer of perfluorooctane sulfonic acid (L-PFOS), as well as perfluorooctane sulfonamide (PFOSA). Table 3 Relationships between eight different PFASs (all ln-transformed) and the intima-media thickness (IMT) (at top) and the echogenicity of the intima-media complex (IM-GSM) (below) in sex-stratified analyses. Relationships are given for non-adjusted and multiple adjusted analyses (HDL-and LDL-cholesterol and serum triglycerides, BMI, blood pressure, smoking exercise habits, energy and alcohol intake, diabetes and educational level). The regression coefficients (Beta), 95%CI and p-values are given for the linear models. For abbreviations of PFASs, see Table 2 .
Sex adjusted
Non-adjusted Multiple adjusted
Beta (95% CI) P-value Beta (95% CI) P-value Lind et al. Environmental Research 152 (2017) 157-164 previously shown that atherosclerosis is associated with other environmental contaminants, like the PCBs (Lind et al., 2012b) , some phthalates (Lind and Lind, 2011) , as well as some metals (Lind et al., 2012a) . The present study adds to that prior knowledge that several environmental contaminants with very different chemical properties, different mechanisms of action and different degrees of exposure are linked to atherosclerosis in the carotid arteries.
IM-GSM
P.M.
Carotid artery plaque
Presence of atherosclerotic plaques in the carotid arteries is a known predictor of future CV events (O'Leary et al., 1999) . Atherosclerosis in the carotid arteries is also known to be predictive for plaques in the coronary circulation (Hulthe et al., 1997) . Thus, subjects with carotid artery plaques are at increased risk also for myocardial infarction. The presently found association between PFUnDA levels and carotid artery plaque in women is therefore of concern. Why this relationship only is seen in women is not known, but it has recently been found that a high level of PFOS is related to sex hormone levels (Joensen et al., 2013) . Since sex hormones seem capable to modulate the development of atherosclerosis (Naessen et al., 2012) it is not unlikely that PFASs could affect men and women in different ways.
Echogenicity of the intima-media complex
The echogenicity of the intima-media complex is closely related to the echogenicity on overt plaques (Lind et al., 2007) , and has been shown to be a powerful predictor of future CV mortality (Wohlin et al., 2009) . The echogenicity of overt plaques has been shown to be related to the structural composition of the plaque (El-Barghouty et al., 1996) , and it is therefore likely that also the echogenicity of the intima-media complex is a marker of composition of the vascular wall. In this case it Table 4 Relationships between eight different PFASs (all ln-transformed) and number of carotid arteries with atherosclerotic plaques. Relationships are given both for sex-adjusted and multiple adjusted analysis (sex, HDL-and LDL-cholesterol and serum triglycerides, BMI, blood pressure, smoking exercise habits, energy and alcohol intake, diabetes and educational level). The odds ratios (OR), 95%CI and p-values are given for the relationships. For abbreviations of PFASs, see Fig. 1 . Relationship between circulating levels of PFUnDA (on a ln-scale, ng mL −1 ) and the echogenicity of the intima-media complex (IM-GSM) in women (FIGURE 1A, p=0.002) and in men (FIGURE 1B, p < 0.05). The predictive margins (and 95%CI) for IM-GSM is given at the y-axis. Fig. 2 . Relationship between circulating levels of PFUnDA (on a ln-scale, ng mL −1 ) and carotid artery plaque in women (p < 0.05). The predictive margins (and 95%CI) for the probability of have carotid artery plaque (and 95%CI) is given at the y-axis.
Table 5
Relationships between eight different PFASs (all ln-transformed) and number of carotid arteries with atherosclerotic plaques in sex-stratified analyses. Relationships are given for multiple adjusted analyses (HDL-and LDL-cholesterol and serum triglycerides, BMI, blood pressure, smoking exercise habits, energy and alcohol intake, diabetes and educational level). The odds ratios (OR), 95%CI and p-values are given for the relationships. For abbreviations of PFASs, see Lind et al. Environmental Research 152 (2017) 157-164 is likely that an echolucent (dark) intima-media complex is indicative of lipid infiltration, while an echogenic (white) intima-media complex possibly represent collagen disposition. In the present study, some of the PFASs, more specifically the longchain PFCAs showed positive relationships vs. IM-GSM in women, but the opposite tendency in men. Thus, most likely these PFCAs are related to an increased lipid infiltration in the vascular wall in men, but more fibrous (collagen) tissue in women. How this translates in terms of risk is hard to tell, since both a low and a high IM-GSM were related to an increased risk (Wohlin et al., 2009 ).
Intima-media thickness
IMT is known as a predictor of CV events, and is usually regarded as a marker of atherosclerosis (O'Leary et al., 1999) . However, atherosclerosis is a disorder of the intima, but IMT is also incorporating the media in the measurement. In the present study, no associations were seen between the PFASs and IMT. This is in contrast to the study by Lin et al who found an association between PFOS levels and IMT in younger subjects (Lin et al., 2013) . The differences in age between the studies might have contributed to the diverse findings. Of interest is the finding of Lin et al that the relationship between PFASs and IMT was mainly found in women, in accordance with findings in the present study.
Other environmental contaminants
Since we previously have reported other environmental contaminants, like the PCBs (Lind et al., 2012b) , some phthalates (Lind and Lind, 2011) , as well as some metals (Lind et al., 2012a) to be related to indices of atherosclerosis, we added PCB209, Cr, Ni, Al, mono-methyl phthalate (MMP) and bisphenol A (BPA) to the models investigating the PFUnDA vs. IM-GSM or carotid plaque relationships, but addition of these other environmental contaminants did not change the PFUnDA vs. IM-GSM or carotid plaque relationships to any significant degree. This is well in line with previous observations that these major environmental contaminants are not closely related and in order to obtain information on the effect of environmental contaminants on a phenotype like atherosclerosis, many different contaminants have to be evaluated (Lampa et al., 2012) .
Potential mechanisms of action
There is no well known obvious explanation for an effect of PFASs on atherosclerosis. PFASs are known to be agonists for the PPAR alpha and gamma receptors (Lau et al., 2007) , although the different PFASs differ regarding binding to these two types of PPAR receptors. Activation of PPAR alpha and gamma-receptors could be different mechanisms be involved in different steps in glucose homeostasis, such as influence on insulin resistance (Lebovitz and Banerji, 2001 ) and insulin secretion (Lupi et al., 2004) , as well as influence circulating levels of lipids (Thomas et al., 2007) and altering the amount of abdominal fat (Moon et al., 2011; Thomas et al., 2007) . In line with this knowledge is our previous findings that some, but not all, of the measured PFASs were related to diabetes in the present sample (Lind et al., 2014) . Diabetes, dyslipidemia and obesity are all known risk factors for atherosclerosis development, but in the present study the association between the PFASs and atherosclerosis was seen independently of these risk factors.
It was mainly the long-chained PFASs that were related to indices of atherosclerosis in the present study, despite that lower concentrations generally were seen for those PFASs. This is hard to explain from experimental data, since it has been shown that PPAR alpha activation occurred in an additive fashion when different PFASs were added to PFOA (Wolf et al., 2014 ), a PFASs with higher concentration than PFUnDA. Structurally, PFUnDA is the 11 carbon version of PFOA and because of its longer carbon chain PFUnDA is more bioaccumulative (Zhang et al., 2013 ). The few available mechanistic studies of PFUnDA found, in line with previous research of other PFASs, that PFUnDA activated the PPAR alpha receptor and inhibited the function of the thyroid hormone (Long et al., 2013; Takahashi et al., 2014) . Moreover, Long et al. (2013) also investigated the effect of PFAAs on the aryl hydrocarbon receptor and found that PFDA and PFDoDA elicited an activating effect but not PFUnDA Thus, no PFUnDA-specific effects have been reported in the available literature. Overall, further experimental studies with regard to PFUnDA and the other long-chain PFCAs are required to gain a deeper insight to the mechanistic pathway by which PFUnDA exerts effects on the arterial wall.
A number of alterations in the immune system, such as T-celldependent antibody responses (DeWitt et al., 2016) , interferon-gamma expression (Ryu et al., 2014) , toll-like receptor 2 (TLR2) expression and activation of interleukins by the NF-κB pathway (Zhang et al., 2014) , and a reduction in IgM antibodies (DeWitt et al., 2016) , have been linked to PFASs exposure. As reviewed by (Libby and Hansson, 2015) an immune reaction against lipid infiltration and trapping in the arterial wall is an early and very important event in the development of atherosclerosis. Future experimental studies have to guide which of these immunological effects of PFASs that could be involved in atherosclerosis development.
It has repeatedly been shown that PFASs levels in humans are related to cholesterol metabolism (Nelson et al., 2010; Skuladottir et al., 2015; Winquist and Steenland, 2014) . In order to test if an effect of PFASs on atherosclerosis is mediated by the effect of PFASs on cholesterol, we performed SEM analyses on the major findings in this study. That analyses disclosed that the mediating role of serum cholesterol significant, but very small (1-3%), regarding the PFUnDA vs. IM-GSM relationship, and not significant regarding the PFUnDA vs. plaque relationship. Thus, in this study, serum cholesterol was not a major mediator of the PFASs vs. atherosclerosis relationship.
In a very recent paper by Lin et al (Lin et al., 2016) it was shown that PFOS was related to circulating microparticles (both endothelium and platelet-derived), as well as to IMT. Furthermore, the link between PFOS and IMT was closer in those with elevated levels of microparticles. Endothelium and platelet-derived microparticles are markers of apoptosis and are linked to endothelial dysfunction, an early feature of atherosclerosis. Thus, with that study a link between PFASs and early atherosclerosis is established.
Limitation of the study
The present sample is limited to Caucasians aged 70. Therefore, caution should be made to draw conclusions to other ethnic and age groups. The present study had a moderate participation rate. However, an analysis of non-participants showed the present sample to be fairly representative of the total population regarding most cardiovascular disorders and drug intake. Furthermore, many statistical tests were performed and thus the present findings since we liked to include not only the most commonly analyzed PFASs, PFOS and PFOA, and we included not only the most commonly used marker of carotid atherosclerosis, IMT, but also information on overt plaques and also on the echogenicity of the arterial wall, IM-GSM, to investigate early changes in the atherosclerotic process. Given the prior limited knowledge in this area on the possible different actions of different PFASs on the vasculature, it was very hard to make any specific prior hypothesis on which PFASs that would be related to a specific marker of atherosclerosis. Using this approach to give a more detailed picture of the relationship between multiple PFASs and three markers of atherosclerosis must hopefully be more valuable than just analyzing two PFASs and IMT, but could produce false positive results due to multiple statistical testing. Our findings must therefore be regarded as exploratory and must therefore be taken with caution until reproduced by others. The finding that two different markers of atherosclerosis, overt plaque and IM-GSM were associated with some PFASs in a fairly consistent manner does however make the present findings likely not to be merely chance findings.
Cross-sectional studies could always be subjected to reverse causation, so ideally prospective studies on plaque progression and development of atherosclerosis-related disorders, such as myocardial infarction and stroke, should be carried out.
Conclusions
In conclusion, in this cross-sectional study, a pronounced gender difference was seen regarding associations between some of the PFASs, especially the long-chain PFCAs such as PFUnDA, and markers of atherosclerosis, with more pronounced relationships found in women. These findings suggest a role for PFASs in atherosclerosis.
